Bowel Cancer
FEATURES
avatar
3608 clinical trials
avatar
855 cell line models
avatar
21 approved drugs
IMAGE
Bowel Cancer
Molecular Synopsis
OVERVIEW
Drugs and clinical candidates

21 drugs have received FDA approval for Bowel Cancer:

  • Bevacizumab
  • Capecitabine
  • Cetuximab
  • Everolimus
  • Fluorouracil
More

406 drugs have a clinical trial registered for Bowel Cancer.

69122 compounds have been tested in Bowel Cancer (44441 <= 500nM potency).

Sources: cancer.gov, clinicaltrials.gov, ChEMBL.

Clinical trials
There are 3608 clinical trials for Bowel Cancer, 1881 of which have one or more drug interventions, 1727 with no drug intervention.
Cell line models

There are 855 Cell Line Models for Bowel Cancer.

Source: COSMIC
Cell line models

Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from clinicaltrials.gov mesh condition terms to Bowel Cancer:
  • Jejunal Neoplasms
  • Rectal Neoplasms
  • Colorectal Neoplasms
  • Sigmoid Neoplasms
  • Gastrointestinal Stromal Tumors
More
The following terms have been mapped from cancer.gov to Bowel Cancer:
  • Colorectal cancer
  • Colorectal cancer in adults and children 12 years and older. It is used alone or with ipilimumab to treat metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) cancer that got worse after treatment with a fluoropyrimidine, oxaliplatin, and irinotecan hydrochloride
  • Colorectal cancer in adults and children 12 years and older. It is used with nivolumab to treat metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) cancer that got worse after treatment with a fluoropyrimidine, oxaliplatin, and irinotecan hydrochloride
  • Anal cancer
  • Colorectal cancer that is advanced
More